GWP
ABBV icon

Gateway Wealth Partners’s AbbVie ABBV Stock Holding History

Gateway Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.32M Sell
17,158
-11,835
-41% -$2.55M 0.26% 102
2026
Q1 		$6.31M Buy
28,993
+25,727
+788% +$5.71M 0.25% 112
2025
Q4 		$746K Buy
3,266
+380
+13% +$86.6K 0.08% 225
2025
Q3 		$668K Buy
2,886
+72
+3% +$14.7K 0.09% 210
2025
Q2 		$522K Sell
2,814
-13
-0.5% -$2.42K 0.1% 195
2025
Q1 		$592K Buy
2,827
+24
+0.9% +$4.67K 0.13% 159
2024
Q4 		$498K Buy
2,803
+17
+0.6% +$3.13K 0.13% 164
2024
Q3 		$550K Buy
2,786
+83
+3% +$15.5K 0.15% 146
2024
Q2 		$464K Buy
2,703
+250
+10% +$41.4K 0.14% 153
2024
Q1 		$447K Buy
2,453
+52
+2% +$8.96K 0.16% 127
2023
Q4 		$372K Sell
2,401
-2,059
-46% -$300K 0.15% 129
2023
Q3 		$665K Buy
4,460
+51
+1% +$7.49K 0.12% 109
2023
Q2 		$594K Sell
4,409
-698
-14% -$102K 0.11% 110
2023
Q1 		$814K Buy
5,107
+500
+11% +$76.4K 0.13% 86
2022
Q4 		$745K Buy
+4,607
New +$706K 0.13% 81

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Gateway Wealth Partners's ABBV Position: Q2 2026 in Review

Gateway Wealth Partners reduced its AbbVie (ABBV) stake by 41% in Q2 2026, selling an estimated $2.55M and leaving 17,158 shares worth $4.32M. The position accounts for 0.26% of the portfolio, ranked #102.

Gateway Wealth Partners first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. The position peaked at $6.31M in Q1 2026. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Gateway Wealth Partners held 17,158 shares of AbbVie worth $4.32M as of Q2 2026.
  • Gateway Wealth Partners sold 11,835 AbbVie shares in Q2 2026, an estimated $2.55M.
  • AbbVie made up 0.26% of Gateway Wealth Partners's portfolio in Q2 2026, its #102 holding.
  • Gateway Wealth Partners first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • Gateway Wealth Partners's AbbVie position peaked at $6.31M in Q1 2026.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Gateway Wealth Partners's 13F filing for Q2 2026, filed 4 Aug 2026.